@article{a90e76edfbbd43778714912dd53dec07,
title = "Development and validation of the Therapy Preference Scale to understand patient{\'s} systemic cancer treatment preferences",
abstract = "We incorporated questions related to safety, effectiveness and other characteristics of systemic cancer treatment into a self-report questionnaire - the Therapy Preference Scale - that captures patient{\'s} preferences. The authors asked 20 experts to assess content validity and an additional 20 experts, patients and community members to examine face validity and guide revisions. Key revisions included shortening the length, clarifying constructs and providing details to explain the context and trade-offs necessary to balance the risks and benefits of cancer treatment. The content validity index for the final questionnaire was 1.0, indicating that all questions were relevant. Reviewers expressed that the questionnaire would serve an important purpose. Experts, patients and community members guided revisions of the questionnaire and documented its value. ",
keywords = "cancer, neoplasm, oncology, patient preference, therapeutics, validation study",
author = "Bhatt, {Vijaya Raj} and Prajwal Dhakal and Wichman, {Christopher S.} and Bunny Pozehl",
note = "Funding Information: V Bhatt reports receiving consulting fees from Takeda, Omeros, Agios, Abbvie, Partner Therapeutics, Rigel, Incyte and Partnership for Health Analytic Research, LLC (funded by Jazz), research funding (institutional) from Jazz, Abbvie, Pfizer, Incyte, Tolero Pharma- ceuticals, Inc., and the National Marrow Donor Program, and drug support for a trial from Oncoceutics. This work was supported by the National Institute of General Medical Sciences, 1 U54 GM115458, which funds the Great Plains IDeA-CTR Network. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed. No writing assistance was utilized in the production of this manuscript. Publisher Copyright: {\textcopyright} 2020 Future Medicine Ltd.. All rights reserved.",
year = "2021",
month = jan,
doi = "10.2217/fon-2020-0497",
language = "English (US)",
volume = "17",
pages = "37--44",
journal = "Future Oncology",
issn = "1479-6694",
publisher = "Future Medicine Ltd.",
number = "1",
}